ApprovalTrail

Natural health product · NPN 80066568

I-Sight

Yes: licensed in Canada

The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.

Licence status Active; licensed January 25, 2016.
Natural Product Number (NPN)
80066568
Licence holder
Xymogen
Dosage form
Capsule
Route
Oral
Licensing route
Non-Traditional
First licensed
January 25, 2016

Medicinal ingredients

Per dosage unit, as licensed.

IngredientAmount
All-trans-lycopene3 mg
2-Aminoethanesulfonic acid200 mg
3,3',4',5,7-Pentahydroxyflavone50 mg
Zinc17.5 mg
Vaccinium myrtillus90 mg
Vaccinium myrtillus—
DL-alpha-Lipoic acid75 mg
L-alpha-Acetamido-beta-mercaptopropionic acid100 mg
Tagetes erecta75 mg
Tagetes erecta—

What it is licensed for

The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.

  • A factor in the maintenance of good health. Helps in connective tissue formation. Helps to maintain healthy skin. Helps the body to metabolize carbohydrates, fats and proteins. Helps to maintain immune function. Provides antioxidants for the maintenance of good health. Antioxidant for the maintenance of good health. Antioxidant for the maintenance of eye health. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. An antioxidant.

Non-medicinal ingredients

Hypromellose; Microcrystalline cellulose; Medium chain triglycerides; Silicon dioxide; Magnesium stearate; Stearic acid